Br J Haematol
- GALLI E, Guarneri A, Corrente A, Portonera FM, et al
Independent validation of the International Metabolic Prognostic Index (CAR-IMPI)
in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T.
Br J Haematol. 2026 Sep 16. doi: 10.1111/bjh.70846.
Eur J Haematol
- DUARTE C, Bosma GN, Abbott D, Jean-Louis G, et al
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment
Modality: A Multicenter Cohort From 14 US Centers.
Eur J Haematol. 2026 Sep 18. doi: 10.1111/ejh.70330.
- KORTLEVE JP, Engels S, Zweers BA, Serroukh Y, et al
Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced-Stage
Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Eur J Haematol. 2026 Sep 16. doi: 10.1111/ejh.70321.
Haematologica
- STELLA F, Fraietta JA, Schuster SJ, Ruella M, et al
T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for
concern?
Haematologica. 2026 Sep 17. doi: 10.3324/haematol.2026.301592.
- KIMURA T, Zaimoku Y, Kawashima H, Yamada S, et al
Phenotype-directed allele-specific flow cytometry identifies HLA-loss relapse
after haploidentical hematopoietic cell transplantation for adult T-cell
leukemia/lymphoma.
Haematologica. 2026 Sep 17. doi: 10.3324/haematol.2026.301574.
Leuk Lymphoma
- BUI TS, Weiner JD, Pierog O, Jedrych J, et al
Beyond the gut: cutaneous manifestations and transformation in indolent T-cell
lymphoma of the gastrointestinal tract.
Leuk Lymphoma. 2026 Sep 16:1-5. doi: 10.1080/10428194.2026.2732620.
- HADDAD GC, Li Y, Hong L, Fu CL, et al
Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a
national cancer database analysis.
Leuk Lymphoma. 2026 Sep 16:1-12. doi: 10.1080/10428194.2026.2728612.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016